Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AP:
-
Alkaline phosphatase
- AML:
-
Acute myeloid leukemia
- ara-C:
-
Cytarabine, cytosine arabinoside
- ara-CMP:
-
Cytosine arabinoside monophosphate
- ara-CTP:
-
Cytosine arabinoside triphosphate
- cdd:
-
Cytidine deaminase
- CLA:
-
Cladarabine/cytarabine
- DNR:
-
Daunorubicin
- dCK:
-
Deoxycytidine kinase
- FLA:
-
Fludarabine/cytarabine
- hENT1:
-
Human equilibrative nucleoside transporter
- IPTG:
-
Isopropyl β-d-1-thiogalactopyranoside
- NPM1:
-
Nucleophosmin-1 gene
- pyrE :
-
Orotate phospho-ribosyltransferase gene
References
Winson MK, Swift S, Hill PJ, Sims CM, Griesmayr G, Bycroft BW, Williams P, Stewart GS (1998) Engineering the luxCDABE genes from P. luminescens to provide a bioluminescent reporter for constitutive and promoter probe plasmids and mini-Tn5 constructs. FEMS Microbiol Lett 163(2):193–202
Salisbury V et al (1999) Use of a clinical Escherichia coli isolate expressing lux genes to study the antimicrobial pharmacodynamics of moxifloxacin. J Antimicrob Chemother 43:829–832
Meighen EA (1991) Molecular biology of bacterial bioluminescence. Microbiol Rev 55:123–142
Beard SJ, Salisbury V, Lewis RJ, Sharpe JA, MacGowan AP (2002) Expression of lux genes in a clinical isolate of Streptococcus pneumoniae: using bioluminescence to monitor gemifloxacin activity. Antimicrob Agents Chemother 46:538–542
Qazi SN, Harrison SE, Self T, Williams P, Hill PJ (2004) Real-time monitoring of intracellular Staphylococcus aureus replication. J Bacteriol 186(4):1065–1077
Robinson GM, Tonks KM, Thorn RM, Reynolds DM (2011) Application of bacterial bioluminescence to assess the efficacy of fast-acting biocides. Antimicrob Agents Chemother 55:5214–5220
Bourgois JJ, Sluse FE, Baguet F, Mallefet J (2001) Kinetics of light emission and oxygen consumption by bioluminescentbacteria. J Bioenerg Biomembr 33:353–363
Luker KE, Luker GD (2008) Applications of bioluminescence imaging to antiviral research and therapy: multiple luciferase enzymes and quantitation. Antiviral Res 78(3):179–187
Andreu N, Zelmer A, Wiles S (2011) Noninvasive biophotonic imaging for studies of infectious disease. FEMS Microbiol Rev 35(2):360–394
Lacharme-Lora L, Perkins SE, Humphrey TJ, Hudson PJ, Salisbury V (2009) Use of bioluminescent bacterial biosensors to investigate the role of free-living helminths as reservoirs and vectors of Salmonella. Environ Microbiol Rep 1(3):198–207
MacKenzie FM, Gould IM (1993) The post-antibiotic effect. J Antimicrob Chemother 32:519–537
Rocchetta HL, Boylan CJ, Foley JW, Iversen PW, LeTourneau DL, McMillian CL, Contag PR, Jenkins DE, Parr TR Jr (2001) Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection. Antimicrob Agents Chemother 45(1):129–137
Alloush HM, Salisbury V, Lewis RJ, MacGowan AP (2003) Pharmacodynamics of linezolid in a clinical isolate of Streptococcus pneumoniae genetically modified to express lux genes. J Antimicrob Chemother 52:511–513
Marques CN, Salisbury VC, Greenman J, Bowker KE, Nelson SM (2005) Discrepancy between viable counts and light output as viability measurements, following ciprofloxacin challenge of self-bioluminescent Pseudomonas aeruginosa biofilms. J Antimicrob Chemother 56:665–671
Thorn RM, Nelson SM, Greenman J (2007) Use of a bioluminescent Pseudomonas aeruginosa strain within an in vitro microbiological system, as a model of wound infection, to assess the antimicrobial efficacy of wound dressings by monitoring light production. Antimicrob Agents Chemother 51:3217–3224
Hancock JT, Salisbury V, Ovejero-Boglione MC, Cherry R, Hoare C, Eisenthal R, Harrison R (2002) Antimicrobial properties of milk: dependence on presence of xanthine oxidase and nitrite. Antimicrob Agents Chemother 46(10):3308–3310
Dhir VK, Dodd CER (1995) Susceptibility of suspended and surface-attached Salmonella enteritidis to biocides and elevated temperatures. Appl Environ Microbiol 61:1731–1738
Choi S, Gu M (1999) A whole cell bioluminescent biosensor for the detection of membrane-damaging toxicity. Biotechnol Bioprocess Eng 4:59–62
Hope KJ, Jin L, Dick JE (2003) Human acute myeloid leukemia stem cells. Arch Med Res 34:507–517
Grimwade D, Walker H, Oliver F et al (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children’s Leukaemia Working Parties. Blood 92(7):2322–2333
Thiede C, Steudel C, Mohr B et al (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 99(12):4326–4335
Gale RE, Green C, Allen C et al (2008) The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia. Blood 111(5):2776
Hiddemann W, Buchner T (2001) Current status and perspectives of therapies for acute myeloid leukaemia. Semin Hematol 38:3–9
Amarante-Mendes GP, Kim CN, Liu L, Huang Y, Perkins CL, Green DR et al (1998) Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase-3. Blood 91:1700–1705
Carter BZ, Kornblau SM, Tsao T, Wang RU, Schober WD, Milella M et al (2003) Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis. Blood 102:4179–4186
Bezombes C, Laurent G, Jaffrezou JP (2003) Implication of raft microdomains in drug induced apoptosis. Curr Med Chem Anticancer Agents 3:263–270
Daher GC, Harris BE, Diasio RB (1990) Metabolism of pyrimidine analogues and their nucleosides. Pharmacol Ther 48:189–222
Jordheim L, Galmarini CM, Dumontet C (2003) Drug resistance to cytotoxic nucleoside analogues. Curr Drug Targets 4:443–460
Smith MA, Smith JG, Pallister CJ, Singer CR (1999) Haematopoietic growth, the cell cycle and sensitivity of AML cells to ara-C. Leuk Lymphoma 23:467–472
Ferrara F (2004) Unanswered questions in acute myeloid leukaemia. Lancet Oncol 5:443–450
Alloush HM, Anderson E, Martin AD, Ruddock MW, Angell JE, Hill PJ, Mehta P, Smith MA, Smith JG, Salisbury VC (2010) A bioluminescent microbial biosensor for in vitro pretreatment assessment of cytarabine efficacy in leukemia. Clin Chem 256(12):1862–1870
Yamauchi T, Negoro E, Kishi S, Takagi K, Yoshida A, Urasaki Y et al (2009) Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5′-nucleotidase II expression ratio in primary acute myeloid leukemia cells. Biochem Pharmacol 77:1780–1786
Hudson MM, Strickland DK, Phipps S, Srivastava DK, Ribeiro RC, Rubnitz JE et al (2000) Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol 18:3273–3279
Jensen KF (1993) The Escherichia coli K-12 “wild types” W3110 and MG1655 have an rph frameshift mutation that leads to pyrimidine starvation due to low pyrE expression levels. J Bact 175:3401–3407
Wang J, Neuhard J, Eriksson S (1998) An Escherichia coli system expressing human deoxyribonucleoside salvage enzymes for evaluation of potential antiproliferative nucleoside analogs. Antimicrob Agents Chemother 42:2620–2625
Kovach ME, Elzer PH, Hill DS, Robertson GT, Farris MA, Roop RM, Peterson KM (1994) Four new derivatives of broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene 166:800–802
Galluzzi L, Karp M (2007) Intracellular redox equilibrium and growth phase affect the performance of luciferase-based biosensors. J Biotech 127:188–198
Cutter KL, Alloush HM, Salisbury VC (2006) Stimulation of DNA repair and increased light output in response to UV irradiation in Escherichia coli expressing lux genes. Luminescence 22:177–181
Kozakiewicz J, Gajewska M, Lyzeńn R, Czyz A, Wegrzyn G (2005) Bioluminescence-mediated stimulation of photoreactivation in bacteria. FEMS Microbiol Lett 250:105–110
Czyz A, Plata K, Wegrzyn G (2002) Induction of light emission by luminescent bacteria treated with UV light and chemical mutagens. J Appl Genet 43:377–389
Anderson E, Conway M, Alloush H et al (2013) Investigation and verification of a bioluminescent biosensor for the quantitation of ara-CTP generation: A biomarker for cytosine arabinoside sensitivity in acute myeloid leukaemia. Biosens Bioelectron 52C:345–353
Anderson E, Smith MA, Martin A et al (2013) A novel bioluminescent bacterial biosensor for measurement of ara-CTP and cytarabine potentiation by fludarabine in seven leukaemic cell lines. Leuk Res 37(6):690–696
Ahlman H, Khorram-Manesh A, Jansson S, Wängberg B, Nilsson O, Jacobsson CE, Lindstedt S (2001) Cytotoxic treatment of adrenocortical carcinoma. World J Surg 25(7):927–933
Volkova M, Russell R 3rd (2011) Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev 7(4):214–220
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Anderson, E., Salisbury, V. (2014). Rapid In-vitro Testing for Chemotherapy Sensitivity in Leukaemia Patients. In: Thouand, G., Marks, R. (eds) Bioluminescence: Fundamentals and Applications in Biotechnology - Volume 2. Advances in Biochemical Engineering/Biotechnology, vol 145. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43619-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-43619-6_6
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43618-9
Online ISBN: 978-3-662-43619-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)